224 related articles for article (PubMed ID: 33377441)
1. Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy.
Whitney DG; Schmidt M; Haapala H
J Manag Care Spec Pharm; 2021 Jan; 27(1):51-63. PubMed ID: 33377441
[No Abstract] [Full Text] [Related]
2. Polypharmacy Among Privately Insured Adults with Cerebral Palsy: A Retrospective Cohort Study.
Whitney DG; Schmidt M; Peterson MD; Haapala H
J Manag Care Spec Pharm; 2020 Sep; 26(9):1153-1161. PubMed ID: 32857655
[TBL] [Abstract][Full Text] [Related]
3. Incidence Rate of Advanced Chronic Kidney Disease Among Privately Insured Adults with Neurodevelopmental Disabilities.
Whitney DG; Schmidt M; Bell S; Morgenstern H; Hirth RA
Clin Epidemiol; 2020; 12():235-243. PubMed ID: 32161503
[TBL] [Abstract][Full Text] [Related]
4. Trajectories of medication use and polypharmacy among children with cerebral palsy.
Pruente J; Daunter AK; Bowman A; Erickson SR; Whibley D; Whitney DG
J Manag Care Spec Pharm; 2023 Jan; 29(1):58-68. PubMed ID: 36580123
[No Abstract] [Full Text] [Related]
5. The effect of low-trauma fracture on one-year mortality rate among privately insured adults with and without neurodevelopmental disabilities.
Whitney DG; Whibley D; Jepsen KJ
Bone; 2019 Dec; 129():115060. PubMed ID: 31494304
[TBL] [Abstract][Full Text] [Related]
6. Advanced CKD Among Adults With Cerebral Palsy: Incidence and Risk Factors.
Whitney DG; Oliverio AL; Kamdar NS; Viglianti BL; Naik A; Schmidt M
Kidney Med; 2020; 2(5):569-577.e1. PubMed ID: 33094275
[TBL] [Abstract][Full Text] [Related]
7. Polypharmacy, chronic kidney disease, and incident fragility fracture: a prospective cohort study.
Wakasugi M; Yokoseki A; Wada M; Momotsu T; Sato K; Kawashima H; Nakamura K; Onodera O; Narita I
J Bone Miner Metab; 2022 Jan; 40(1):157-166. PubMed ID: 34729651
[TBL] [Abstract][Full Text] [Related]
8. Association of Polypharmacy with Kidney Disease Progression in Adults with CKD.
Kimura H; Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
Clin J Am Soc Nephrol; 2021 Dec; 16(12):1797-1804. PubMed ID: 34782408
[TBL] [Abstract][Full Text] [Related]
9. International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study.
Hayward S; Hole B; Denholm R; Duncan P; Morris JE; Fraser SDS; Payne RA; Roderick P; Chesnaye NC; Wanner C; Drechsler C; Postorino M; Porto G; Szymczak M; Evans M; Dekker FW; Jager KJ; Caskey FJ;
Nephrol Dial Transplant; 2021 Feb; 36(3):503-511. PubMed ID: 32543669
[TBL] [Abstract][Full Text] [Related]
10. Nontrauma fracture increases risk for respiratory disease among adults with cerebral palsy.
Whitney DG
J Orthop Res; 2020 Dec; 38(12):2551-2558. PubMed ID: 32233002
[TBL] [Abstract][Full Text] [Related]
11. Nephrotoxic Medication Exposure in U.S. Adults with Predialysis Chronic Kidney Disease: Health Services Utilization and Cost Outcomes.
Davis-Ajami ML; Fink JC; Wu J
J Manag Care Spec Pharm; 2016 Aug; 22(8):959-68. PubMed ID: 27459659
[TBL] [Abstract][Full Text] [Related]
12. Psychological morbidity among adults with cerebral palsy and spina bifida.
Peterson MD; Lin P; Kamdar N; Mahmoudi E; Marsack-Topolewski CN; Haapala H; Muraszko K; Hurvitz EA
Psychol Med; 2021 Mar; 51(4):694-701. PubMed ID: 32713401
[TBL] [Abstract][Full Text] [Related]
13. Association of healthy lifestyle and all-cause mortality according to medication burden.
Kelly NA; Soroka O; Onyebeke C; Pinheiro LC; Banerjee S; Safford MM; Goyal P
J Am Geriatr Soc; 2022 Feb; 70(2):415-428. PubMed ID: 34695226
[TBL] [Abstract][Full Text] [Related]
14. Risk of advanced chronic kidney disease among adults with spina bifida.
Whitney DG; Pruente J; Schmidt M
Ann Epidemiol; 2020 Mar; 43():71-74.e1. PubMed ID: 32014336
[TBL] [Abstract][Full Text] [Related]
15. The association between polypharmacy and health-related quality of life among non-dialysis chronic kidney disease patients.
Adjeroh L; Brothers T; Shawwa K; Ikram M; Al-Mamun MA
PLoS One; 2023; 18(11):e0293912. PubMed ID: 37956162
[TBL] [Abstract][Full Text] [Related]
16. The cardiovascular disease burden of non-traumatic fractures for adults with and without cerebral palsy.
Whitney DG; Bell S; Etter JP; Prisby RD
Bone; 2020 Jul; 136():115376. PubMed ID: 32335375
[TBL] [Abstract][Full Text] [Related]
17. Cardiometabolic Morbidity in Adults With Cerebral Palsy and Spina Bifida.
Peterson MD; Lin P; Kamdar N; Mahmoudi E; Schmidt MM; Haapala HJ; Hurvitz EA
Am J Med; 2020 Dec; 133(12):e695-e705. PubMed ID: 32687812
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from The English Longitudinal Study of Ageing (ELSA).
Slater N; White S; Venables R; Frisher M
BMJ Open; 2018 Mar; 8(3):e020270. PubMed ID: 29540422
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. The association of degree of polypharmacy before and after among hospitalised internal medicine patients and clinical outcomes: a retrospective, population-based cohort study.
Jonsdottir F; Blondal AB; Gudmundsson A; Bates I; Stevenson JM; Sigurdsson MI
BMJ Open; 2024 Mar; 14(3):e078890. PubMed ID: 38548367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
